NCT02702011 - Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 20, 2016

Primary Completion Date

September 5, 2016

Study Completion Date

October 3, 2016

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

empagliflozin medium dose

DRUG

empagliflozin low dose

DRUG

empagliflozin high dose

DRUG

placebo

Trial Locations (4)

Souseikai Hakata Clinic, Fukuoka, Fukuoka

Nishikumamoto Hospital, Kumamoto, Kumamoto

Shinjuku Research Park Clinic, Tokyo, Shinjyuku-ku

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku